Femasys FEMY
NASDAQ FEMY
$1.42 +0.05 (+3.65%)
At close: Nov 9, 2026 · 4:00 PM EST

Femasys (FEMY) Gains from Sales and Divestitures (2021 - 2025)

Updated

Femasys (FEMY) recorded Gains from Sales and Divestitures of -$9,477 in Q4 2025, compared with -$676.00 a year earlier.

Analysis

Femasys (FEMY) Gains from Sales and Divestitures (2021 - 2025) Analysis & Trends

For FY2025, Femasys reported Gains from Sales and Divestitures of -$62,650.

  • Across earlier years, Gains from Sales and Divestitures came in at -$676.00 in FY2024, -$47,538 in FY2023, -$2,285 in FY2022 and -$3,098 in FY2021.
  • Quarterly Gains from Sales and Divestitures has ranged from -$43,507 in Q1 2025 to -$248.00 in Q4 2021 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 267.71 Bn 244.23 Bn 5.13 Bn
2 Abbott Laboratories 191.69 Bn 165.56 Bn 7.39 Bn
3 Danaher 166.18 Bn 145.83 Bn 3.84 Bn
4 Intuitive Surgical 161.07 Bn 141.36 Bn 2.08 Bn
5 Medtronic 131.65 Bn 96.90 Bn 6.34 Bn
6 Stryker 125.25 Bn 111.44 Bn 4.25 Bn
7 Boston Scientific 63.85 Bn 59.29 Bn 3.43 Bn
8 Edwards Lifesciences 60.52 Bn 43.72 Bn 1.35 Bn
9 Becton Dickinson 59.08 Bn 56.23 Bn 2.32 Bn
10 Femasys 4.87 Mn -15.80 Mn 189,391.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -9,477.00
Jun 30, 2025 -9,666.00
Mar 31, 2025 -43,507.00
Dec 31, 2024 -676.00
Dec 31, 2023 -3,000.00
Dec 31, 2022 -2,285.00
Dec 31, 2021 -248.00
API Access

Femasys Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=FEMY&period=max&api_key=YOUR_API_KEY